RAREPIG

Company

Ultragenyx Pharmaceutical Inc.

Filed

August 11, 2014

Accession Number

0000318989-14-000103

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →